Navigating the Intersection between Genomic Research and Clinical Practice

Cancer Prev Res (Phila). 2020 Mar;13(3):219-222. doi: 10.1158/1940-6207.CAPR-19-0267.

Abstract

The Risk Assessment Program (RAP) at Fox Chase Cancer Center (Philadelphia, PA) is a multi-generational prospective cohort, enhanced for personal and family history of cancer, consisting of over 10,000 individuals for whom data on personal and family history of cancer, risk factors, genetic and genomic data, health behaviors, and biospecimens are available. The RAP has a broad research agenda including the characterization of genes with known or potential relevance to cancer, gene-gene and gene-environment interactions, and their contribution to clinically useful risk assessment and risk reduction strategies. Increasingly, this body of research is identifying genetic changes which may have clinical significance for RAP research participants, leading us to confront the issue of whether to return genetic results emerging from research laboratories. This review will describe some of the important fundamental points that must be debated as we develop a paradigm for return of research results. The key issues to address as the scientific community moves toward adopting a policy of return of research results include the best criteria for determining which results to offer, the consent document components necessary to ensure that the participant makes a truly informed decision about receiving their results, and associated logistical and cost challenges.See all articles in this Special Collection Honoring Paul F. Engstrom, MD, Champion of Cancer Prevention.

Publication types

  • Research Support, N.I.H., Extramural
  • Review

MeSH terms

  • Bioethical Issues / legislation & jurisprudence
  • Bioethical Issues / standards
  • Consensus
  • Consent Forms
  • Decision Making
  • Disclosure / ethics*
  • Disclosure / legislation & jurisprudence
  • Disclosure / standards
  • Ethics Committees, Research / standards
  • Gene-Environment Interaction
  • Genetic Predisposition to Disease
  • Genetic Testing / ethics*
  • Genetic Testing / legislation & jurisprudence
  • Genetic Testing / standards
  • Genomics / ethics*
  • Genomics / legislation & jurisprudence
  • Genomics / standards
  • Humans
  • Information Dissemination / ethics
  • Information Dissemination / legislation & jurisprudence
  • Medical History Taking
  • Neoplasms / epidemiology
  • Neoplasms / genetics*
  • Neoplasms / prevention & control
  • Prospective Studies*
  • Registries / ethics
  • Registries / standards
  • Risk Assessment / legislation & jurisprudence